[4]
Corman, V.M. Hosts and sources of endemic human coronaviruses. In: Advances in virus research; Elsevier, 2018; pp. 163-188.
[19]
Yasmin, F.; Yaqub, T.; Khan, I.; Shahzad, W.; Abu Saeed, H.; Tahir, Z.; Mukhtar, N.; Umar, S. Antiviral activity of thiazolide derivatives against dengue virus in Huh-7 cell line J. Microbiol., 2018, 11(2), e62467/1-e62467/6.
[25]
Sabbagh, E.; Baraka, M.M.; Ibrahim, S.M.; Pannecouque, C.; Andrei, G.; Snoeck, R.; Balzarini, J.; Rashad, A. Synthesis and antiviral activity of new pyrazole and thiazole derivatives Eur. J. Med. Chem., 2009, 44, 3746-3753.
[42]
Brown, D.J. Pyrimidines and their benzo derivatives Compre. Heterocyclic Chem., 1984, 3, 57-155.
[46]
Dansena, H.; Dhongade, H.; Chandrakar, K. Pharmacological potentials of pyrimidine derivative: a review Asian J. Pharm. Clin. Res., 2015, 8(4), 171-177.
[48]
Gordon, W.; John, A. A critical review of the 2005 literature preceded by two chapters on current heterocyclic topics Prog. Heterocyclic Chem., 2007, 18, 126-149.
[60]
Skorobogatyi, M.V. 5-Arylethynyl-2′-deoxyuridines, compounds active against HSV-1 Organic. Biomolecular. Chem., 2006, 4(6), 1091-1096.
[64]
Xu, A.; Zhou, N.; Zhang, X. Preparation and antiviral activity of pyrazolopyridinyl pyrimidines Faming Zhuanli Shenqing. Patent: CN 112724130 A, 2021.
[65]
Naffakh, N.; Crepin, T.; Vidalain, P.-O.; Pietrancosta, N.; Le Corre, L.; Busca, P.; Ashraf, U.; Corio, A.; Gravier-Pelletier, C. Antiviral and anti-cancer activity of pyrido[2,3-d]pyrimidine and oxadiazole compounds. Patent: EP 3722295 A1, 2020.
[66]
Naffakh, N.; Crepin, T.; Vidalain, P-O.; Pietrancosta, N.; Le Corre, L.; Busca, P.; Ashraf, U.; Corio, A.; Gravier-Pelletier, C. Anti-viral and anti-cancer activity of pyrido[2,3-d]pyrimidine and oxadiazole compounds. Patent:WO 2020208236 A1, 2020.
[67]
Kiselev, O. I.; Chupakhin, O. N.; Charushin, V. N.; Rusinov, V. L.; Deeva, E. G.; Ulomskii, E. N. Injection or infusion solution of Larginine salt of 5-methyl-6-nitro-1,2,4-triazolo[1,5-a]pyrimidin-7- one monohydrate for therapy of influenza and other viral infections. Patent: RU 2586283 C1, 2016.
[68]
Chupakhin, O.N.; Rusinov, V.L.; Ulomskii, E.N.; Charushin, V.N.; Petrov, A.Yu.; Kiselev, O.I. Sodium salt 5-methyl-6-nitro- 1,2,4-triazole[1,5-a]pyrimidine-7-one dehydrate Patent:RU
2330036 C1, 2008.
[69]
Hu, Y.; Lou, L.; Cheng, G.; Xu, Y.; Xie, F.; Tang, W.; Li, J. Method for preparation of new type of small molecule pyrimidine derivatives with antitumor and antivirus activities. Patent:WO
2007104254 A1, 2007.
[70]
Li, A.; Jadaf, P. K.; Yao, Y.; Chen, Y.; Cao, G. Preparation of pyrimidinamine derivatives as Jak kinase inhibitor and used for preventing and/or treating diseases or disorders related to Jak kinase activity or expression, Faming Zhuanli Shenqing. Patent: CN 113372351 A, 2021.
[71]
Yao, Y.; Li, A.; Jadaf, P. K.; Cao, G. Preparation of (pyrimidinyl) thiadiazabicyclo[3.2.1]octane derivatives as JAK kinase inhibitor and used for preventing and/or treating diseases or disorders related to JAK kinase activity or expression. Patent: CN 113372364 A, 2021.
[72]
Kim, P. H.; Kim, S. H. Novel pyrimidine derivative and use thereof. WO 2021125803 A1 20210624, 2021.
[73]
Liu, Q.; Khosla, C.; Gupta, A. Enhancing the antiviral efficacy of RNA virus inhibition by combination with modulators of pyrimidine metabolism. Patent:WO 2021011572 A1, 2021.
[74]
Moesslacher, J.; Battisti, V.; Langer, T.; Urban, E.; Puerstinger, G.; Abdelnabi, R.; Delang, L.; Jochmans, D.; Leyssen, P.; Marchand, A. Preparation of substituted pyrimidinylpiperazines as antiviral compounds. Patent: WO 2020221894 A1, 2020.
[75]
Li, Y.; Li, Z.; Cen, S.; Peng, Z.; Li, J.; Wang, Y.; Quan, Y.; Zhou, R. Aroyl piperazine compounds with inhibitory activity to hepatitis C virus as well as Zika virus replication, preparation method and application thereof in antivirus. Patent: CN 110590708 A, 2019.
[76]
Kim, Jong U.; Lee, Sang Uk; Lee, Geun Hyeong; Han, Jae Jin; Park, Sang Jin; Park, Eul Yong; Shin, Jung Cheol Lim, Jong Hwan 2-(Methylthio)pyrimidine derivatives, their preparation method, and antiviral composition containing them, Repub. Patent: KR 2008061613 A, 2008.
[77]
Herdewijn, P.A.M.M.; De Jonghe, S.C.A.; Watkins, W.J.; Chong, L.S.; Zhang, J. Pyrido[3,2-d]pyrimidines as antiviral agents and their pharmaceutical compositions and use in the treatment of viral infections. Patent:WO 2008009076 A2, 2008.
[78]
Venkateshappa, C.; Duraiswamy, A.J.; Putta, R.K.V.P. Pyrimidine derivatives as inhibitors of PD1/PD-L1 activation and their preparation. Patent: IN 201741039535 A, 2019.
[79]
Pellacini, F.; Ungheri, D.; Schioppacassi, G.; Kraus, J-L.; Camplo, M.; Mourier, N.; Chermann, J-C. Preparation of pyrimidinone-1,3-oxathiolane nucleosides as antiviral agents. Patent:WO 9843972
A1, 1998.
[80]
Son, J. C.; Lee, I. Y.; Kim, H. S.; Kim, J. C.; Cho, E. H.; Chung, S. G.; Kim, J. Y.; Lee, S. H.; Kwon, H. S.; Lee, J. W. Preparation of 2,4-pyrimidinedione acyclic nucleosides as virucides for AIDS treatment. Patent: WO 9743266 A1, 1997.
[81]
Cho, E. H.; Chung, S. G.; Kim, J. Y.; Kwon, H. S.; Lee, S. H.; Lee, J. E.; Joo, J. H.; Kim, B. C.; Kang, D. W. Preparation of substituted pyrimidinedione homo-carbocyclic nucleosides as virucides. Patent: WO 9730979 A1, 1997.
[82]
D’cruz, O.; Uckun, F.M.; Venkatachalam, T. Preparation of AZT derivatives exhibiting spermicidal and anti-viral activity. US 20020025922 A1, 2002.
[83]
Wang, T.; Zhang, Z.; Meanwell, N.A.; Kadow, J.F.; Yin, Z.; Xue, Q.M.; Regueiro-Ren, A.; Matiskella, J.D.; Ueda, Y. Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives. Patent:US 20040110785 A1, 2004.
[84]
Son, J. C.; Lee, I. Y.; Bae, B. I.; Han, J. S.; Choi, J. K.; Chae, Y. B. Novel antiviral 2,4-pyrimidinedione derivatives and processes for the preparation thereof. Patent:WO 9518109 A1 19950706, 1995.
[85]
Gavegnano, C.; Schinazi, R.F. Antiviral pyrrolo[2,3-b]pyridine and pyrrolo[2,3-b]pyrimidine JAK inhibitors useful in treating or preventing retroviral and other viral infections. Patent:US
20190134039 A1, 2019.
[86]
Zhang, H.; Pan, T.; Luo, H.; Zhang, X.; Bai, C. Application of 1- (2-chlorophenyl)-4-{thieno [3,2-d]pyrimidin-4-yl} piperazine compound in preparing anti-HIV-1 drugs. Patent: CN 103893183 A, 2014.
[87]
Fan, X.; Zhang, X.; Li, X.; Wang, Y.; Xu, H.; Guo, S.; He, Y. 5- Substituted pyrimidine nucleoside-thiazolinone hybrid compound with anti-HIV activity and preparation method. Patent: CN 103242400 A, 2013.
[88]
Wang, Q.; Wang, C.; Li, Y.; Tan, J.; Wang, M.; Yao, X.; Qiao, W.; Geng, Y.; Liu, Y.; Wang, Li. Preparation of pyrimidineamide derivatives with anti-HIV and anti-TMV activity. Patent:A 20130605, 2013.
[89]
Chaltin, P.; Debyser, Z.; De Maeyer, M.; Marchand, A.; Marchand, D.; Smets, W.; Voet, A.; Christ, Fr. Pyrimidine derivatives as novel viral replication inhibitors and their preparation and use in the treatment of HIV infection. Patent: WO 2011015641 A1, 2011.
[90]
Wang, T.; Zhang, Z.; Meanwell, Ni. Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives. Patent: US 20030207910 A1, 2003.
[91]
Pedersen, E.B.; Jorgensen, P. Preparation of anti-retroviral 5,6- disubstituted acyclo-pyrimidine nucleoside derivatives Patent: WO 2003057677 A1, 2003.
[92]
Lori, F.; De Forni, D.; Stevens, M.R. Anti-proliferative substituted pyrazolo[3,4-d]pyrimidines derivatives (SPP) to inhibit immune activation, virus replication and tumor growth Patent: WO 2011014239 A1, 2011.
[93]
Cho, U. H.; Jung, S. G.; Myung, H. N.; Kwon, H. S.; Lee, S. H.; Lee, J. U.; Ju, J. Antiviral pyrimidinedione derivatives. Patent: KR 2007103536 A, 2007.
[94]
Zemlicka, J.; Qiu, Y.-l.; Drach, J. C.; Ptak, R. G. Preparation of 2- hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents. Patent: S 6352991 B1, 2002.
[95]
Tets, V. V.; Tets, G. V.; Krasnov, K. A. Drug preparation with antiviral activity (versions). Patent: WO 2016159836 A1, 2016.
[96]
Chu, C. K.; Otto, M. J.; Shi, J.; Schinazi, R.F.; Choi, Y.; Gumina, G. Preparation, antiviral activity, and cytotoxicity of β-2'- and 3'- halo-nucleosides. Patent: WO 2003000200 A2, 2003.
[97]
Kim, J.W.; Chung, K.H.; Ahn, S.K.; Son, H.J.; Jeong, B.S. Preparation of nucleosides as anti-hepatitis-B virucides Patent:WO 9716456 A1, 1997.
[98]
Guo, X.; Tao, Y.; Li, Y.; Dong, L.; Liu, L.; Wang, Q.; Yu, X. 4-amino acid substituted pyrimidine nucleoside compound and application thereof in preparing antiviral myocarditis drugs and anticoxsackie virus drugs. Patent: CN 109265504 A, 2019.
[99]
Lancois, D. F. A.; Guillemont, J. E. G.; Raboisson, P. J.-M. B.; Roymans, D. A. E.; Rogovoy, B.; Bichko, V.; Lardeau, D. Y. R.; Michaut, A. B. Preparation of pyrazolo- and triazolo-pyrimidine compounds as RSV antiviral agents. Patent: WO 2016174079 A1, 2016.
[100]
Tahri, A.; Vendeville, S.M.H.; Jonckers, T.H.M.; Raboisson, P.J.-M.B.; Demin, S.D.; Hu, L. Preparation of piperidine substituted tricyclic pyrazolo[1,5-a]pyrimidine derivatives as respiratory syncytial virus inhibitors Patent: WO 2016091791 A1, 2016.
[101]
Tahri, A.; Vendeville, S. M. H.; Jonckers, T. H. M.; Raboisson, P. J.-M. B.; Demin, S. D.; Hu, L.; Cooymans, L. P. Preparation of piperidine substituted pyrazolo[1,5-a]pyrimidine derivatives as respiratory syncytial virus inhibitors. Patent: WO 2016091774 A1, 2016.
[102]
Wutzler, P.; Schmidtke, M.; Makarov, V. Process for production of 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidines. Patent: DE 102011116373 A1, 2013.
[103]
Yoshimura, Y.; Sato, H.; Matsuda, A.; Ashida, N.; Machida, H. Preparation of 2'-deoxy-2'-methylidene-4'-thiopyrimidine nucleosides as antiviral agents. Patent: JP 09087295 A, 1997.
[104]
Townsend, L. B.; Drach, J. C.; Renau, T. E. Pyrrolo[2,3-d]pyrimidine derivatives as antivirals. Patent: WO 9523151 A1, 1995.
[105]
Ashkinazi, R. I.; Ganina, M. B.; Studentsov, E. P. Bioactive substance containing derivatives of 2-amino-6-(aryloxy)pyrimidines and intermediate products of their synthesis. Patent: WO 2001019801 A1, 2001.
[106]
Herdewijn, P.; Wang, J.; De Clercq, E. Preparation of carbocyclic nucleosides as antiviral agents. Patent: WO 2001018003 A1, 2001.
[107]
Tets, V.V.; Tets, G.V.; Krutikov, V.I. Preparation of 2,4-dioxo-5-(2-hydroxy-3,5-dichlorobenzylidene)imino-1,3-pyrimidine sodium, potassium and ammonium salts having antimicrobial activity. Patent: RU 2260590 C1, 2005.
[108]
Hertel, L.W.; Kroin, J.S. 2'-deoxy-2',2'-difluoro-(4-substituted pyrimidine) nucleosides having antiviral and anti-cancer activity and intermediates. Patent: EP 576230 A1, 1993.
[109]
Townsend, L. B.; Drach, J. G.; Shipman, C., Jr; Pudlo, J. S. Preparation of acyclic pyrrolo(2,3-d)pyrimidine nucleoside analogs as antiviral agents. Patent: US 4968686 A, 1990.
[110]
Antiviral and antitumor-enhancing activities of pyrimidin-2-ones. Patent: US 940273 A0, 1987.
[111]
Bardos, T. J.; Cheng, Y. C.; Schroeder, A. C. Inhibition of the replication of DNA viruses with 5-substituted 2-pyrimidinone nucleosides. Patent: US 4468384 A, 1984.
[112]
Shealy, Y. Carbocyclic analogs of uracil nucleosides as antiviral agents. Patent: US 4396623 A, 1983.
[113]
Townsend, L.B.; Drach, J.C. Preparation of pyrrolo[2,3-d]pyrimidines as antiviral agents Patent: US 6342501 B1, 2002.
[114]
Balzarini, J.; Camarasa, M. J.; Velazquez, S. Improvements in or relating to compositions for the treatment or prophylaxis of viral infections, especially varicella zoster virus, by using nucleoside analogs esterified at 3 and/or 5 positions by neutral non-polar amino acid, or oligopeptide. Patent: WO 2009030410 A1, 2009.
[115]
Asraf, M.A.; Hossen, M.F.; Bitu, N.A.; Uddin, M.E.; Islam, M.R.; Zamir, R.; Zahan, M.K. Antiviral Compounds: A Road to Quest for Novel Antiviral Drugs Ann Med Chem, 2020, 1(1), 1004.
[126]
Koszytkowska-Stawinska, M. Process for the preparation of new phosphono-substituted azanucleosides. Patent: PL 215487 B1, 2013.
[127]
Cornaglia, F. P.; Stradi, R. Preparation of pyrimidine derivatives with pharmacological activities. Patent: IT 91MI0978 A1, 1992.
[128]
Zhang, S.; Xiong, G. Antiviral composition of (R)-9-[2- (phosphorylmethoxy)propyl]adenine and (2R,cis)-4-amino-1-(2- hydroxymethyl-1,3-oxathiolan-5-yl)-pyrimidin-2-one. Patent: CN 101584701 A, 2009.
[129]
Balzarini, J.; Camarasa, M.J.; Velazquez, S. Improvements in or relating to compositions for the treatment or prophylaxis of viral infections, especially varicella zoster virus, by using nucleoside analogs esterified at 3 and/or 5 positions by neutral non-polar amino acid, or oligopeptide. Patent: GB 2452556 A, 2009.
[130]
Cho, D. G.; Cho, U. Y.; Choi, J. R.; Hwang, J. T.; Jang, H. S.; Kim, E. G.; Kim, J. M.; Lee, J. H.; Lim, J. H.; Noh, G. Y. Preparation of antiviral 2,4-pyrimidinedione derivatives. Patent: KR 2002074683 A, 2002.
[131]
Sonn, J. C.; Lee, I. Y.; Bae, B. I.; Han, J. S.; Choe, J. K.; Chae, Y. B. A novel process for the preparation of antiviral 2,4- pyrimidinedione derivatives. Patent: KR 151815 B1, 1998.
[132]
Loebering, H. G.; Miestereck, H. Pyrimidine nucleosides esterified in position 5' having antiviral activity and medicinal compositions containing them. Patent: EP 56265 A2, 1982.
[133]
Keppeler, K.; Kiefer, G. Substituted pyrimidine nucleosides with an antiviral activity and drug forms prepared with them. Patent: DE 3045375 A1, 1982.
[134]
Kiefer, G.; Keppeler, K. Substituted pyrimidine nucleosides with antiviral and cytostatic activity. Patent: DE 3045342 A1, 1982.
[135]
Grinev, A.N.; Kharizomenova, I.A.; Panisheva, E.K.; Tolstikova, E.V.; Bogdanova, N.S.; Nikolaeva, I.S.; Peters, V.V.; Pershin, G.N. Derivatives of 3-(p-benzoquinonylimino)-4-oxo-3,4- dihydrothieno[2,3-d]pyrimidine with antivirus activity. Patent: SU 677345 A1, 1980.
[136]
Slusarchyk, W. A.; Zahler, R. Preparation of an optically active [bis(hydroxymethyl)cyclobutyl]pyrimidine derivative as an antiviral agent. Patent: EP 484843 A1, 1992.
[137]
Kaplina, N. V.; Shvedov, V. I.; Fomina, A. N.; Nikolaeva, I. S.; Pushkina, T. V.; Filitis, L. N. Thieno-[2,3-d]pyrimidines having herpes virus inhibitory and antituberculosis activities. Patent: SU 1389235 A1, 1993.
[138]
Ichikawa, Y.; Ishikawa, F.; Matsuo, K.; Aoyama, K.; Nishiyama, Y.; Matsubara, K.; Nagahata, T.; Hoshino, H.; Seki, J. Preparation of 1-[3-(hydroxymethyl)cyclobutyl]pyrimidine derivatives as virucides. Patent: JP 02028161 A, 1990.
[139]
Marquez, V.E.; Driscoll, J.S. Preparation of cyclopentenylpyrimidine and -purine derivatives as antiviral and antitumor agents. Patent: US 307115 A0, 1989.
[140]
Takaku, H.; Yoshida, S.; Aoki, T.; Akiba, K. Preparation of acyclic nucleosides cyclic phosphoramidates having antiviral and anticancer activities. Patent: JP 63165373 A, 1988.
[141]
Holy, A.; Rosenberg, I.; De Clercq, E. Preparation and testing of N-phosphonylmethoxyalkyl derivatives of pyrimidine and purine bases with antiviral activity Patent: EP 253412 A2, 1988.
[142]
Gatti, D. Pyrimidine derivatives endowed with antiviral activity. Patent: EP 124810 A1, 1984.
[143]
Jiang, C.; He, H.; Xu, L.; Lin, G. Preparation of anti-virus nucleoside analogs. Patent: CN 1563006 A, 2005.
[144]
Miyasaka, T.; Tanaka, H.; De Clercq, E.D.A.; Baba, M.; Walker, R.T.; Ubasawa, M. 6-substituted acyclic pyrimidine nucleoside derivatives and antiviral agents containing same as active ingredients. Patent: WO 8909213 A1, 1989.
